1Y Close · As of Aug 26, 2026
TELCON RF PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: TELCON RF PHARMACEUTICAL. Inc.
In fiscal year 2025, TELCON RF PHARMACEUTICAL (200230) reported revenue of 43.2 billion KRW, up 14.0% from 37.9 billion KRW a year earlier.
Operating profit was 719 million KRW and net income was -11.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 21.0 billion KRW, with a P/B of 0.19.
These figures can be verified in the DART filing (receipt no. 20260319001306).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 43.2B | 719M | -11.4B |
| 2024 | 37.9B | -71M | -26.5B |
| 2023 | 36.3B | 965M | 13.9B |
| 2022 | 27.8B | -4.1B | -42.1B |
| 2021 | 37.8B | -2.7B | -23.2B |
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Unable to determine due to missing data.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-07-31 | Conversion Price Adjustment |